Medtronic plc (MDT) is currently Undervalued by 31.82%

Instant valuation answer

Medtronic plc (MDT) appears undervalued by approximately 31.82% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

  • Upside (live) 31.82% (from live valuation API)
  • Confidence (live) 8/10 (High)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$83.06

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Why is Medtronic plc overvalued or undervalued?

Intrinsic value work anchors Medtronic plc on owner earnings and balance-sheet capacity; the current quote trades below that anchor, which frames the stock as relatively cheap on a fundamentals-first view.

Versus historical valuation bands, MDT is closer to the lower end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.

Forward market expectations are muted: the price does not require heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.

Key metrics

P/E ratio
24.6x
Revenue growth (TTM y/y)
15%
Profit margin
21.8%
Fair value (model)
Unlock

Frequently asked questions — MDT

Is MDT overvalued right now?

A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for MDT, then validate with fundamentals and peer multiples.

What is Medtronic plc's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether MDT trades above or below fair value. At $83.06, Medtronic plc currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Medtronic plc's intrinsic value calculated?

Tickerplace calculates MDT's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is MDT undervalued right now?

Based on our 2026 valuation models, Medtronic plc (MDT) appears undervalued at $83.06 with about 31.8% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.

Peers for MDT: open their overvalued / undervalued view.